Objectives Salivary duct carcinoma (SDC) is a rare, aggressive malignancy with a poor
prognosis. These tumors frequently stain positive for HER2/ErbB2, but data on the …

Background Salivary duct carcinoma (SDC) is associated with aggressive clinical behavior.
Methods We examined the prognostic values of clinicopathologic variables and hypoxia …

Context.—Immunohistochemical stains for androgen receptor (AR), HER-2/neu, and p53 are
used as diagnostic markers associated with malignancy in several histologic types of …

Salivary gland tumors are rare, clinically diverse neoplasms that represent less than 1% of
all malignancies. In locoregional recurrent or metastatic disease, systemic therapy is the …

Several proliferation markers, such as DNA ploidy, Ki67, MiB1 and proliferating cell nuclear
antigen have been shown to correlate with clinical course and prognosis in several …

Salivary duct carcinomas (SDCs) and adenoid cystic carcinomas (ACCs) are the most
aggressive and the most frequent carcinomas of the salivary glands, respectively. Little is …

Materials and methods Malignant intraoral salivary gland tumors diagnosed at the
Departments of Oral Pathology at the University of Pretoria and Medical University of …

Salivary gland tumors are a heterogeneous group of neoplasms representing less than 10%
of all head and neck tumors. Among salivary gland tumors, salivary duct carcinoma (SDC) is …

Salivary duct carcinoma is a highly malignant adenocarcinoma of salivary origin. Its
pathologic features are distinct from the other salivary gland tumors and bear a remarkable …

Salivary duct carcinoma (SDC) is a high-grade adenocarcinoma arising from the ductal
epithelium of salivary glands which rarely involves the minor salivary glands. The varied …